Evidence map›Paper›PMID 38606968›Full record

ArticlemSphere2024

Monitoring ESBL-

Sheena Conforti, Aurélie Holschneider, Émile Sylvestre, Timothy R Julian

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cross-sectoral sharing of CTX-M-producingMicrobiology spectrum · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prevalence of Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sheena ConfortiEawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland.ORCID 0000-0002-0173-6170
Aurélie HolschneiderEawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland.
Émile SylvestreEawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland.ORCID 0000-0001-6537-2313
Timothy R JulianEawag, Swiss Federal Institute of Aquatic Science and Technology, Dübendorf, Switzerland.ORCID 0000-0003-1000-0306
Swiss Federal Institute of Aquatic Science and Technology · CHSIB Swiss Institute of Bioinformatics · CHSwiss Tropical and Public Health Institute · CH

Funding

Swiss National Science Foundation 192763
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a global health threat, causing millions of deaths annually, with expectations of increased impact in the future. Wastewater surveillance offers a cost-effective, non-invasive tool to understand AMR carriage trends within a population. We monitored extended-spectrum β-lactamase producing IMPORTANCE: Antimicrobial resistance (AMR) is a global health threat and is commonly monitored in clinical settings, given its association with the risk of antimicrobial-resistant infections. Nevertheless, tracking AMR within a community proves challenging due to the substantial sample size required for a representative population, along with high associated costs and privacy concerns. By investigating high resolution temporal and geographic trends in extended-spectrum beta-lactamase producing

Indexed as

beta-LactamasesEscherichia coliWastewaterAnti-Bacterial AgentsCarrier StateEscherichia coli InfectionsHumansSwitzerlandAnti-Bacterial Agentsbeta-LactamasesWastewaterantimicrobial resistanceESBL-E. colimolecular methodsSwitzerlandwastewater-based epidemiology

Identifiers

PMID38606968
PMCPMC11328990
OpenAlexW4394734725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.